Report Sections

See All Reports

  • HP:0001511: Intrauterine growth retardation
  • Pneumonia (359) Respiratory tract infection (38) Neoplasm (36) Abnormality of the cardiovascular system (34) Diabetes mellitus (33) Depressivity (29) Acute kidney injury (27) Hypoxemia (26) Hypertension (24) Abnormal lung morphology (24) Thromboembolism (22) Anosmia (20) Myocardial infarction (20) Arthritis (19) Type II diabetes mellitus (18) Stroke (16) Pulmonary embolism (16) Mental deterioration (15) Abnormality of coagulation (15) Pulmonary fibrosis (15) Chronic pulmonary obstruction (15) Abnormality of the kidney (14) Autistic behavior (14) Rheumatoid arthritis (14) Leukemia (14) Interstitial pneumonitis (14) Pulmonary obstruction (14) Asthma (13) Chronic pain (13) Congestive heart failure (12) Deep venous thrombosis (12) Neoplasm of the lung (12) Autism (11) Obesity (11) Respiratory distress (11) Colitis (11) Ulcerative colitis (11) Crohn's disease (11) Type I diabetes mellitus (10) Abnormality of the liver (9) Coronary artery atherosclerosis (9) Inflammation of the large intestine (9) Pulmonary insufficiency (9) Chronic kidney disease (9) Myocarditis (9) Behavioral abnormality (8) Psychosis (8) Dementia (8) Alzheimer disease (8) Carcinoma (8) Low levels of vitamin D (8) Sepsis (8) Infertility (7) Peripheral arterial stenosis (7) Renal insufficiency (6) Lymphopenia (6) Dysphagia (6) Lymphoma (6) Systemic lupus erythematosus (6) Osteoarthritis (6) Breast carcinoma (6) Psoriasiform dermatitis (6) Abnormality of the gastrointestinal tract (6) Fatigue (6) Encephalopathy (5) Premature birth (5) Bronchiectasis (5) Difficulty walking (5) Gastroparesis (5) Immunodeficiency (5) Obstructive sleep apnea (5) Autoimmunity (5) Knee osteoarthritis (5) Sleep apnea (5) Prostate cancer (5) Allergy (5) Non-small cell lung carcinoma (5) Schizophrenia (5) Neoplasm of the large intestine (5) Seizure (4) Hepatic fibrosis (4) Cardiac arrest (4) Weight loss (4) Migraine (4) Pulmonary arterial hypertension (4) Abnormal intestine morphology (4) Neoplasm of the pancreas (4) Colon cancer (4) Malnutrition (4) Paroxysmal atrial fibrillation (4) Disseminated intravascular coagulation (4) Attention deficit hyperactivity disorder (4) Inflammatory abnormality of the skin (4) Neoplasm of head and neck (4) Endometriosis (4) Addictive behavior (4) Hypercoagulability (4) Insomnia (4) Obsessive-compulsive behavior (3) Eczema (3) Atopic dermatitis (3) Spastic diplegia (3) Abnormal heart morphology (3) Cardiomyopathy (3) Fever (3) Hypothermia (3) Headache (3) Celiac disease (3) Reduced factor VIII activity (3) Lymphoid leukemia (3) Renal cell carcinoma (3) Abnormal anterior horn cell morphology (3) Amyotrophic lateral sclerosis (3) Cystoid macular edema (3) Arrhythmia (3) Cutaneous melanoma (3) Pulmonary edema (3) Ovarian neoplasm (3) Neuroendocrine neoplasm (3) Hypogeusia (2) Hearing impairment (2) Abnormality of the eye (2) Visual impairment (2) Conjunctivitis (2) Cataract (2) Uveitis (2) Agoraphobia (2) Abnormality of the endocrine system (2) Abnormality of the skin (2) Jaundice (2) Lymphedema (2) Spasticity (2) Meningitis (2) Abnormal joint morphology (2) Hepatic steatosis (2) Hepatic failure (2) Tachycardia (2) Angina pectoris (2) Pancreatitis (2) Abnormality of blood and blood-forming tissues (2) Thrombocytopenia (2) Autoimmune thrombocytopenia (2) Gout (2) Diarrhea (2) Gastroesophageal reflux (2) Apnea (2) Neurodegeneration (2) Alopecia of scalp (2) Mutism (2) Transient ischemic attack (2) Hyperkinetic movements (2) Polyphagia (2) Hypotension (2) Atherosclerosis (2) Hypoventilation (2) Squamous cell carcinoma (2) Myelodysplasia (2) Back pain (2) Low back pain (2) Muscular dystrophy (2) Stillbirth (2) Acute myeloid leukemia (2) Lymphoproliferative disorder (2) Myeloproliferative disorder (2) Multiple myeloma (2) Intervertebral disc degeneration (2) Stridor (2) Postprandial hyperglycemia (2) Hemeralopia (2) Arteritis (2) Hepatitis (2) Glioblastoma multiforme (2) Cervix cancer (2) Small cell lung carcinoma (2) Endocarditis (2) Toxemia of pregnancy (2) Myositis (2) Mania (2) Urinary retention (1) Urinary incontinence (1) Nephritis (1) Menorrhagia (1) Xerostomia (1) Otitis media (1) Conductive hearing impairment (1) Amblyopia (1) Periodontitis (1) IgA deposition in the glomerulus (1) Enuresis (1) Hypoparathyroidism (1) Adrenal insufficiency (1) Hyperaldosteronism (1) Osteopenia (1) Urticaria (1) Angiokeratoma corporis diffusum (1) Cholecystitis (1) Keratoconjunctivitis (1) Intellectual disability (1) Hemiparesis (1) Polyneuropathy (1) Syncope (1) Cerebral hemorrhage (1) Hepatocellular carcinoma (1) Intrauterine growth retardation (1) Hoarse voice (1) Dysphonia (1) Weak voice (1) Sudden cardiac death (1) Aortic valve stenosis (1) Bradycardia (1) Torsade de pointes (1) Atrioventricular block (1) Premature rupture of membranes (1) Dehydration (1) Constipation (1) Anorexia (1) Esophageal varix (1) Chorea (1) Status epilepticus (1) Subarachnoid hemorrhage (1) Abnormality of the spinal cord (1) Memory impairment (1) Encephalitis (1) Spina bifida (1) Language impairment (1) Waddling gait (1) Increased intracranial pressure (1) Biliary cirrhosis (1) Dilatation (1) Osteomyelitis (1) Central apnea (1) Hypokalemia (1) Hyponatremia (1) Hyperphosphatemia (1) Skeletal muscle atrophy (1) Male infertility (1) Spondylolisthesis (1) Myalgia (1) Bruxism (1) Neonatal death (1) Increased body weight (1) Intermittent claudication (1) Thrombophlebitis (1) Chronic bronchitis (1) Ventricular tachycardia (1) Acute myelomonocytic leukemia (1) Dilatation of the cerebral artery (1) Coronary artery stenosis (1) Venous insufficiency (1) Chronic lymphatic leukemia (1) Abnormality of bone marrow cell morphology (1) Hypersensitivity pneumonitis (1) Intraalveolar phospholipid accumulation (1) Neoplasm of the genitourinary tract (1) Neoplasm of the skin (1) Female infertility (1) Benign prostatic hyperplasia (1) Hip osteoarthritis (1) Bladder neoplasm (1) Stomatitis (1) Uterine neoplasm (1) Intestinal atresia (1) Placental abruption (1) Sinus tachycardia (1) Bronchiolitis (1) Erythroid hypoplasia (1) Asterixis (1) Hodgkin lymphoma (1) B-cell lymphoma (1) Ciliary dyskinesia (1) Myeloid leukemia (1) Chronic myelomonocytic leukemia (1) Morphea (1) Bronchitis (1) Hypercapnia (1) Pain (1) Retinal vein occlusion (1) Vasovagal syncope (1) Heart block (1) Cough (1) Neonatal asphyxia (1) Dyspareunia (1) Heart murmur (1) Cardiogenic shock (1) Cholangitis (1) Cholangiocarcinoma (1) Vulvar neoplasm (1) Neonatal sepsis (1) Glue ear (1) Abnormality of movement (1) Subdural hemorrhage (1) Biliary tract neoplasm (1) Nasal polyposis (1) Eclampsia (1) Esophagitis (1) Vaginal neoplasm (1) Cellulitis (1) Angioedema (1) Self-injurious behavior (1) Gastrointestinal stroma tumor (1) Bulimia (1) Neoplasm of the rectum (1) Chest pain (1) Atelectasis (1) Lymphocytosis (1) Polymenorrhea (1)

    HP:0001511: Intrauterine growth retardation

    Developed by Shray Alag, The Harker School
    Sections: Correlations, Clinical Trials, and HPO

    Correlations computed by analyzing all clinical trials.

    Navigate: Clinical Trials and HPO


    Correlated Drug Terms (2)


    Name (Synonyms) Correlation
    drug1703 Healthy lifestyle advise Wiki 1.00
    drug1446 Exercise program Wiki 0.71

    Correlated MeSH Terms (5)


    Name (Synonyms) Correlation
    D005317 Fetal Growth Retardation NIH 1.00
    D000078064 Gestational Weight Gain NIH 1.00
    D015430 Weight Gain NIH 1.00
    Name (Synonyms) Correlation
    D046110 Hypertension, Pregnancy-Induced NIH 0.71
    D011248 Pregnancy Complications NIH 0.32

    Correlated HPO Terms (1)


    Name (Synonyms) Correlation
    HP:0004324 Increased body weight HPO 1.00

    Clinical Trials

    Navigate: Correlations   HPO

    There is one clinical trial.


    1 Active Pregnancy, Prevention Against the Effects of COVID-19

    Historically and traditionally, the recommendations related to physical exercise during pregnancy have been based more on moral or cultural issues than on scientific evidence. During some phases of history, pregnancy has meant a period of seclusion for women (not only physical). One of the adverse consequences has been the common recommendation of rest as a general rule for pregnant women. Scientific evidence from recent years has achieved a better understanding of the process of pregnancy and childbirth as well as maternal and fetal responses to exercise. Currently, both from a scientific and clinical/obstetric point of view, there is no doubt about the benefits of an active pregnancy for entire body of pregnant woman, and even her child. In fact, risks of a sedentary lifestyle are applicable to the pregnancy situation, even more with important associated complications during pregnancy and postpartum period. Unfortunately, the impact of COVID-19 has caused an unprecedented global crisis, in this sense the necessary measures taken by the different administrations, especially in terms of confinement causes (from now on) a large number of complications affecting different populations. In summary a complex situation without established prevention strategies exists. The pregnant population is, due to the nature of the gestation and delivery process, one of the population groups with the highest risk of adverse outcomes and associated complications and whose consequences include the mother, fetus, newborn and even children. According to an important body of scientific literature and based on an epigenetic effect, the intrauterine environment can be a determining factor for the future human being to evolve regardless of complications and pathologies (cardiovascular, metabolic, psychic, emotional). This is demonstrated by numerous recent scientific evidences that confirm the unfortunate association between an adverse intrauterine environment (due to various factors) and observable postnatal pathologies in infants. In addition, current publications report the large number and variety of alterations that the COVID-19 situation causes in pregnant women and that includes the entire female organism. This complex situation does not only affect aspects of a physical or physiological nature, but also psychic and emotional factors. In summary, a new state of confinement or similar situations in the near future (impossibility of groupings, distance between people), avoid during the daily life of pregnant women one of the important and recent recommendations made by the international scientific community: a pregnancy physically active. This is especially relevant, due to the dangerous association between complications of a psychological or emotional nature during pregnancy with pre, peri and postnatal disorders (low birth weights, perinatal complications, altered and prolonged deliveries, etc.), which affect not only to the mother and can determine the health of the future human being. According to the scientific literature and based on an epigenetic effect, the intrauterine environment can be a determining aspect in the health of the future human being and the prevention of complications and pathologies (cardiovascular, metabolic, psychic, emotional). This is demonstrated by numerous and recent scientific evidences that confirm the unfortunate association between an adverse intrauterine environment (due to various factors) and different pathologies during and after pregnancy. It is evident the change that COVID-19 and its effects will generate in the lifestyle of the pregnant population and the increased probability of suffering associated pathologies in the next 24-36 months. No preventive actions have yet been planned in Spain and its public hospitals against the impact of COVID-19 on the quality of life of pregnant women. It is urgent to design and perform an adequate strategy of intervention for its possible prevention. From the scientific point of view, the recommendations are clear and concrete, an aerobic exercise program, designed and supervised by professionals from the Sciences of Physical Activity and Sports, is the best option for pregnant women. In this sense, in the last 30 years, physical exercise has proven to have many benefits for pregnant women, without causing risks or adverse effects on maternal-fetal well-being. This is confirmed by an important body of scientific literature on gestational physical exercise and its effects on pregnancy outcomes.

    NCT04563065
    Conditions
    1. Pregnancy Complications
    2. Pregnancy, High Risk
    3. Pregnancy Induced Hypertension
    4. Newborn Morbidity
    5. Fetal Growth Retardation
    6. Fetus Disorder
    7. Weight Gain, Maternal
    8. Maternal-Fetal Relations
    Interventions
    1. Other: Exercise program
    2. Other: Healthy lifestyle advise
    MeSH:Pregnancy Complications Fetal Growth Retardation Hypertension, Pregnancy-Induced Weight Gain Gestational Weight Gain
    HPO:Increased body weight Intrauterine growth retardation

    Primary Outcomes

    Description: analyze the increase during pregnancy

    Measure: Maternal weight gain

    Time: 9 months

    Description: analyze how it varies during pregnancy

    Measure: blood pressure

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: OGTT-O'Sullivan test

    Time: 1 month

    Description: analyze with a questionnaire the value and its interrelationship with physical exercise patterns (different measures in the questionnaire)

    Measure: Urinary Incontinence Questionnaire (ICIQ-SF)

    Time: 9 months

    Description: analyze with a questionnaire the value and its interrelationship with physical exercise patterns (Likert scale 0-3)

    Measure: State-Trait Anxiety Inventory (STAI)

    Time: 9 months

    Description: analyze with a questionnaire the variability during pregnancy (Likert scale 0-3)

    Measure: depression scale (CES-D)

    Time: 9 months

    Description: analyze variability during pregnancy

    Measure: Behavior of Fetal Heart Rate

    Time: 3 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: gestational age

    Time: 9 months

    Description: analyze whether women have had a vaginal, instrumental or cesarean delivery and its interrelationship with physical exercise patterns

    Measure: type of delivery (Vaginal, instrumental or cesarean)

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: duration of labor

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: birthweight

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy

    Measure: child's weight

    Time: 24 months

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy

    Measure: child's height

    Time: 24 months

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy (Likert scale 0-3)

    Measure: mental assessment of the child (depression questionnaire adapted to childhood)

    Time: 24 months

    Secondary Outcomes

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Maternal pains during pregnancy (headache, back pain, pelvic pain, paravertebral, scapular, etc.)

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: fetal growth and development

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Delivery tears

    Time: 1 month

    Description: analyze the appearance (descriptive: yes/no) and its interrelationship with physical exercise patterns

    Measure: performing episiotomy during childbirth

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Apgar Score

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: length

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: cranial perimeter

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Landau reflexes test

    Time: 1 month

    Description: analyze the number of admissions and its interrelationship with physical exercise patterns

    Measure: neonatal intensive care unit (NICU)

    Time: 1 month

    Description: analyze how it varies during postpartum period

    Measure: Postpartum recovery of pre-pregnancy weight

    Time: 12 months

    Description: analyze with a questionnaire how it varies during postpartum period (Likert scale 0-3)

    Measure: Edinburgh Postpartum Depression Scale (EPDS)

    Time: 12 months

    Other Outcomes

    Description: analyze the value and its interrelationship with physical exercise patterns (Likert scale)

    Measure: Perception of health status - SF36 health scale

    Time: 24 months

    Description: analyze the diameter and thickness of muscles in the perineal area and its interrelationship with physical exercise patterns

    Measure: Recovery of pelvic floor muscles ultrasound

    Time: 6 months

    Description: analyzewith a questionnaire how it varies during and after pregnancy

    Measure: Maternal habits of physical activity - Pregnancy Physical Activity Questionnaire (PPAQ)

    Time: 12 months

    HPO Nodes


    HP:0001511: Intrauterine growth retardation
    Genes 641
    DKC1 SMARCA4 HES7 RNASEH2A GLIS3 FOXH1 NDUFS6 HDAC6 OBSL1 MESD LAGE3 ORC6 IGF1 RNU4ATAC LMNA SMARCB1 XYLT1 PSAT1 SF3B4 SEMA5A GP1BB GATA4 FANCI KCNJ11 MLXIPL CDON ADGRG6 TARS1 PRKAR1A SEC61A1 NSD2 SEC24C RAB18 PAH EXOSC9 DYNC2LI1 NELFA CPLX1 ATP6V0A2 SEC24D QRICH1 DPF2 PNPT1 FLT4 BLK TINF2 ERCC8 NSD2 PIEZO2 SLC25A24 SLX4 TUFM CDK10 FGF8 TRIP13 ERCC1 RNU4ATAC CEL WARS2 SMARCAL1 ORC1 GTF2E2 AFF2 GDF1 RAD51 GJA5 TINF2 JMJD1C IARS1 UFD1 NIN ERCC4 CREBBP ASXL1 LMNA ERCC2 HYLS1 SDHA ORC1 EIF2AK3 SEC31A RNU4ATAC NEUROD1 CNOT1 BMPER POLE ARID1A PCDH12 PIGG FANCL ERCC6 NDUFA1 NDUFA11 PRPS1 ORC6 SOX4 NDUFAF4 EVC RNU4ATAC CDT1 MUSK GTPBP3 PDX1 ATRIP MBTPS2 KIF2A COQ2 MYORG DOK7 LIFR FBLN5 NUP188 ATP6V0A2 OTUD6B COQ7 KIF5C FLVCR2 GATA6 TTC37 GINS1 RFWD3 TSFM RNF113A GFM1 SIX3 CITED2 NDUFAF5 HNF1A LETM1 EFEMP2 RTEL1 PTDSS1 MCM4 P4HB GCK DHDDS KMT2A KIF14 FANCE STRA6 ATP6V1A RAD21 PHGDH WRAP53 GATA4 GATB TMEM70 ERCC1 RBM10 UQCRFS1 GLI3 RFX6 PIGG SLC25A24 B3GLCT ARID2 ATP6V1E1 FANCI BLM PDGFRB PCNT FANCM PDX1 SMAD4 PDX1 SMARCAL1 DLL1 NDUFAF3 NDUFS4 CENPJ SMARCE1 BCR UBR1 OSGEP IARS1 PSAT1 FTO NIPBL NCAPG2 PCNT FLT1 YY1 RPL11 PARN NOP10 HHAT SOX11 PLAGL1 ND3 TBX4 CDT1 ZFP57 GFM2 EVC2 NODAL WDR73 TUBGCP6 NODAL HDAC6 LETM1 RARB NIPBL STT3B FANCG TBX6 FMR1 GATA6 SRPX2 TMEM126B TBCE RPS19 NDUFAF1 H19-ICR ATP7A WNT4 MTRR PEX2 RTEL1 ARL6IP6 FLI1 HNF4A SAMD9 BUB1B TRAIP TOR1A PHGDH SFXN4 NDUFA6 SLC26A2 ORC4 RERE CENPE MYOD1 PDGFB HDAC8 TIMMDC1 NDUFA10 TRAPPC11 ERCC6 ALDH18A1 INS PUF60 TTC37 STT3B ARID1B RPL10 SC5D TOP3A RAF1 MCM5 PALB2 SMARCD1 SKIV2L SON TFAP2A FAM20C PCGF2 POLR3A BUB1B HYMAI WARS2 SMC1A CHRNA1 ZNF335 HYMAI GMNN ZIC2 GAS1 TCTN3 ERCC6 CHRND PCNT FKTN TDGF1 NDUFB11 TIMM22 PDSS2 FANCL ABCC8 COG5 DYRK1A ND2 TGIF1 CDKN1C FANCB CHRNG BRAF ERCC8 ZMPSTE24 FIG4 HMGA2 PLK4 INS NUBPL DISP1 DNAJC21 PARN ERCC5 WNT7A LEMD3 NUS1 DKC1 GFM2 PLK4 STN1 IGF2 RIPK4 TBCE CKAP2L ACD ATP7A KLF11 NSUN2 FANCB GLI2 SIX2 SMPD4 ARCN1 NDUFA6 RBBP8 CHD7 NUP107 CRKL DLL3 CTC1 DHCR7 NDUFAF8 GLI3 RBM10 BUB3 RB1 LIG4 NALCN INS DNMT3A SUFU CUL7 TBCE COG7 DYRK1A UQCC2 TMEM216 PLOD3 TBX1 SMC1A NDUFB3 HOXD13 CHRNG PSAT1 ESCO2 BRIP1 RTTN PPP1R15B ABL1 WASHC5 CTU2 DDX11 NDUFV1 PKLR RREB1 ALX4 CEP57 ATP6V0A2 NDUFS7 RAD51C ARVCF ERCC5 ABCC8 FGFR1 CDCA7 TBX1 RECQL4 MKS1 IGHMBP2 SETD5 GLI1 ALG1 FANCF NIN KLHL7 TGDS PIK3R1 TRAIP TRMT10A ZMPSTE24 ALDH18A1 SDHD NDUFS2 WHCR ZFP57 FANCD2 APPL1 PLK4 SMARCB1 NUP88 STOX1 ESCO2 PTPN11 ATR XRCC2 BRPF1 TMEM70 POLA1 ND1 RIPPLY2 PDE4D PSPH TFAM CDKN1C MRPS28 WDR4 NDUFS3 NSDHL NDUFAF2 SEMA3E PHGDH VANGL2 FGFR1 SLC35A2 BRIP1 GATAD2B CLCN7 ADGRG1 NUP133 ERCC3 COG4 NHP2 KMT2A CEP152 OTUD6B SLC18A3 SLC25A13 BRCA2 TAPT1 INSR FDFT1 NKX2-6 INS CORIN NDUFS8 DKC1 NDUFAF4 PI4KA ABCB7 FOXRED1 MPLKIP CDC6 KAT6A SNRPB TTC7A QRSL1 ORC4 PARN PAX4 NDUFB10 COG1 MCTP2 COQ9 NPM1 PRKDC SLC20A2 DNAJC19 EP300 BRCA1 CEP290 UBR1 GCK STRA6 RAPSN FANCC NEK9 TRIM37 IFIH1 DHCR7 AARS1 SDHAF1 PTCH1 UBE2T FAM111A SUCLG1 SOX11 MUSK YY1 CDC6 CKAP2L IGF1R RAB3GAP2 CARS1 HMGA2 NDUFB11 TTC7A INSR ASXL1 POLE PLAGL1 NDUFS1 SMARCE1 GATA6 CTDP1 RERE TFAP2A CCDC8 CTC1 FUT8 COMT HYMAI DONSON UNC80 NDUFV2 TBX1 PDE6D OSGEP SMAD4 NDUFB3 CTNND2 GPKOW SHH MYH3 NOS3 LAGE3 GATA5 DONSON CCNQ MTHFR PIEZO2 NFIX NDUFAF8 ATR ERCC2 COG6 TERC PDX1 TBC1D20 TP53RK ADAT3 CDC45 SMC3 STAG1 ABCC8 BCS1L TAF1 HADH GBA PDE4D ESCO2 LARS2 SMARCA4 VPS13B NDUFAF5 XRCC4 FANCA TCTN3 SMARCC2 MAD2L2 JAG1 NKX2-5 BLM TPRKB RAB3GAP1 RFWD3 TERT STAT3 KCNJ11 FLNB XPR1 RTEL1 DYRK1A KCNJ11 WDR4 CTBP1 FBN1 IBA57 WDR73 IGF1 TALDO1 BRCA2 CNOT1 SIN3A CENPE SMARCA2 FGFRL1 ERCC1 TINF2 BUB1 LFNG INSR CUL7 KANSL1 ALG8 ELN POLA1 DHCR24 NDE1 ARID1B BCS1L MAPK1 TERT ATP5F1A KCNJ11 RNF113A CENPJ BCAP31 USB1 B3GLCT EMG1 POLR3A SMC1A HIRA NDUFB9 SRCAP JAM2 TUBGCP4 GTF2E2 SKIV2L TINF2 PEX5 GATC GTF2H5 ZFPM2 ACD HSD11B2 DNAJC19 MESP2 TELO2 COQ4 CEP57 RNU4ATAC PDE4D TBCE ERCC2 ITPA NBN GCK KDM6A CDKN1C UNC80 PYCR1 PPP1R15B ABCC8 IGF1R SDHB
    Protein Mutations 1
    G20210A
    SNP 0

    HPO

    Alphabetical listing of all HPO terms. Navigate: Correlations   Clinical Trials


    HPO Nodes


    HP:0001511: Intrauterine growth retardation
    Genes 641
    DKC1 SMARCA4 HES7 RNASEH2A GLIS3 FOXH1 NDUFS6 HDAC6 OBSL1 MESD LAGE3 ORC6 IGF1 RNU4ATAC LMNA SMARCB1 XYLT1 PSAT1 SF3B4 SEMA5A GP1BB GATA4 FANCI KCNJ11 MLXIPL CDON ADGRG6 TARS1 PRKAR1A SEC61A1 NSD2 SEC24C RAB18 PAH EXOSC9 DYNC2LI1 NELFA CPLX1 ATP6V0A2 SEC24D QRICH1 DPF2 PNPT1 FLT4 BLK TINF2 ERCC8 NSD2 PIEZO2 SLC25A24 SLX4 TUFM CDK10 FGF8 TRIP13 ERCC1 RNU4ATAC CEL WARS2 SMARCAL1 ORC1 GTF2E2 AFF2 GDF1 RAD51 GJA5 TINF2 JMJD1C IARS1 UFD1 NIN ERCC4 CREBBP ASXL1 LMNA ERCC2 HYLS1 SDHA ORC1 EIF2AK3 SEC31A RNU4ATAC NEUROD1 CNOT1 BMPER POLE ARID1A PCDH12 PIGG FANCL ERCC6 NDUFA1 NDUFA11 PRPS1 ORC6 SOX4 NDUFAF4 EVC RNU4ATAC CDT1 MUSK GTPBP3 PDX1 ATRIP MBTPS2 KIF2A COQ2 MYORG DOK7 LIFR FBLN5 NUP188 ATP6V0A2 OTUD6B COQ7 KIF5C FLVCR2 GATA6 TTC37 GINS1 RFWD3 TSFM RNF113A GFM1 SIX3 CITED2 NDUFAF5 HNF1A LETM1 EFEMP2 RTEL1 PTDSS1 MCM4 P4HB GCK DHDDS KMT2A KIF14 FANCE STRA6 ATP6V1A RAD21 PHGDH WRAP53 GATA4 GATB TMEM70 ERCC1 RBM10 UQCRFS1 GLI3 RFX6 PIGG SLC25A24 B3GLCT ARID2 ATP6V1E1 FANCI BLM PDGFRB PCNT FANCM PDX1 SMAD4 PDX1 SMARCAL1 DLL1 NDUFAF3 NDUFS4 CENPJ SMARCE1 BCR UBR1 OSGEP IARS1 PSAT1 FTO NIPBL NCAPG2 PCNT FLT1 YY1 RPL11 PARN NOP10 HHAT SOX11 PLAGL1 ND3 TBX4 CDT1 ZFP57 GFM2 EVC2 NODAL WDR73 TUBGCP6 NODAL HDAC6 LETM1 RARB NIPBL STT3B FANCG TBX6 FMR1 GATA6 SRPX2 TMEM126B TBCE RPS19 NDUFAF1 H19-ICR ATP7A WNT4 MTRR PEX2 RTEL1 ARL6IP6 FLI1 HNF4A SAMD9 BUB1B TRAIP TOR1A PHGDH SFXN4 NDUFA6 SLC26A2 ORC4 RERE CENPE MYOD1 PDGFB HDAC8 TIMMDC1 NDUFA10 TRAPPC11 ERCC6 ALDH18A1 INS PUF60 TTC37 STT3B ARID1B RPL10 SC5D TOP3A RAF1 MCM5 PALB2 SMARCD1 SKIV2L SON TFAP2A FAM20C PCGF2 POLR3A BUB1B HYMAI WARS2 SMC1A CHRNA1 ZNF335 HYMAI GMNN ZIC2 GAS1 TCTN3 ERCC6 CHRND PCNT FKTN TDGF1 NDUFB11 TIMM22 PDSS2 FANCL ABCC8 COG5 DYRK1A ND2 TGIF1 CDKN1C FANCB CHRNG BRAF ERCC8 ZMPSTE24 FIG4 HMGA2 PLK4 INS NUBPL DISP1 DNAJC21 PARN ERCC5 WNT7A LEMD3 NUS1 DKC1 GFM2 PLK4 STN1 IGF2 RIPK4 TBCE CKAP2L ACD ATP7A KLF11 NSUN2 FANCB GLI2 SIX2 SMPD4 ARCN1 NDUFA6 RBBP8 CHD7 NUP107 CRKL DLL3 CTC1 DHCR7 NDUFAF8 GLI3 RBM10 BUB3 RB1 LIG4 NALCN INS DNMT3A SUFU CUL7 TBCE COG7 DYRK1A UQCC2 TMEM216 PLOD3 TBX1 SMC1A NDUFB3 HOXD13 CHRNG PSAT1 ESCO2 BRIP1 RTTN PPP1R15B ABL1 WASHC5 CTU2 DDX11 NDUFV1 PKLR RREB1 ALX4 CEP57 ATP6V0A2 NDUFS7 RAD51C ARVCF ERCC5 ABCC8 FGFR1 CDCA7 TBX1 RECQL4 MKS1 IGHMBP2 SETD5 GLI1 ALG1 FANCF NIN KLHL7 TGDS PIK3R1 TRAIP TRMT10A ZMPSTE24 ALDH18A1 SDHD NDUFS2 WHCR ZFP57 FANCD2 APPL1 PLK4 SMARCB1 NUP88 STOX1 ESCO2 PTPN11 ATR XRCC2 BRPF1 TMEM70 POLA1 ND1 RIPPLY2 PDE4D PSPH TFAM CDKN1C MRPS28 WDR4 NDUFS3 NSDHL NDUFAF2 SEMA3E PHGDH VANGL2 FGFR1 SLC35A2 BRIP1 GATAD2B CLCN7 ADGRG1 NUP133 ERCC3 COG4 NHP2 KMT2A CEP152 OTUD6B SLC18A3 SLC25A13 BRCA2 TAPT1 INSR FDFT1 NKX2-6 INS CORIN NDUFS8 DKC1 NDUFAF4 PI4KA ABCB7 FOXRED1 MPLKIP CDC6 KAT6A SNRPB TTC7A QRSL1 ORC4 PARN PAX4 NDUFB10 COG1 MCTP2 COQ9 NPM1 PRKDC SLC20A2 DNAJC19 EP300 BRCA1 CEP290 UBR1 GCK STRA6 RAPSN FANCC NEK9 TRIM37 IFIH1 DHCR7 AARS1 SDHAF1 PTCH1 UBE2T FAM111A SUCLG1 SOX11 MUSK YY1 CDC6 CKAP2L IGF1R RAB3GAP2 CARS1 HMGA2 NDUFB11 TTC7A INSR ASXL1 POLE PLAGL1 NDUFS1 SMARCE1 GATA6 CTDP1 RERE TFAP2A CCDC8 CTC1 FUT8 COMT HYMAI DONSON UNC80 NDUFV2 TBX1 PDE6D OSGEP SMAD4 NDUFB3 CTNND2 GPKOW SHH MYH3 NOS3 LAGE3 GATA5 DONSON CCNQ MTHFR PIEZO2 NFIX NDUFAF8 ATR ERCC2 COG6 TERC PDX1 TBC1D20 TP53RK ADAT3 CDC45 SMC3 STAG1 ABCC8 BCS1L TAF1 HADH GBA PDE4D ESCO2 LARS2 SMARCA4 VPS13B NDUFAF5 XRCC4 FANCA TCTN3 SMARCC2 MAD2L2 JAG1 NKX2-5 BLM TPRKB RAB3GAP1 RFWD3 TERT STAT3 KCNJ11 FLNB XPR1 RTEL1 DYRK1A KCNJ11 WDR4 CTBP1 FBN1 IBA57 WDR73 IGF1 TALDO1 BRCA2 CNOT1 SIN3A CENPE SMARCA2 FGFRL1 ERCC1 TINF2 BUB1 LFNG INSR CUL7 KANSL1 ALG8 ELN POLA1 DHCR24 NDE1 ARID1B BCS1L MAPK1 TERT ATP5F1A KCNJ11 RNF113A CENPJ BCAP31 USB1 B3GLCT EMG1 POLR3A SMC1A HIRA NDUFB9 SRCAP JAM2 TUBGCP4 GTF2E2 SKIV2L TINF2 PEX5 GATC GTF2H5 ZFPM2 ACD HSD11B2 DNAJC19 MESP2 TELO2 COQ4 CEP57 RNU4ATAC PDE4D TBCE ERCC2 ITPA NBN GCK KDM6A CDKN1C UNC80 PYCR1 PPP1R15B ABCC8 IGF1R SDHB
    Protein Mutations 1
    G20210A
    SNP 0

    Reports

    Data processed on September 26, 2020.

    An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.

    Drug Reports   MeSH Reports   HPO Reports  

    Interventions

    4,180 reports on interventions/drugs

    MeSH

    691 reports on MeSH terms

    HPO

    263 reports on HPO terms

    All Terms

    Alphabetical index of all Terms

    Google Colab

    Python example via Google Colab Notebook